Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 1993 Feb;86(2):96–100.

The current debate concerning beta-agonists in asthma: a review.

K F Chung 1
PMCID: PMC1293859  PMID: 8094459

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arvidsson P., Larsson S., Löfdahl C. G., Melander B., Svedmyr N., Wåhlander L. Inhaled formoterol during one year in asthma: a comparison with salbutamol. Eur Respir J. 1991 Nov;4(10):1168–1173. [PubMed] [Google Scholar]
  2. Bel E. H., Zwinderman A. H., Timmers M. C., Dijkman J. H., Sterk P. J. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease. Thorax. 1991 Jan;46(1):9–14. doi: 10.1136/thx.46.1.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Beswick K. B., Pover G. M., Sampson S. Long-term regularly inhaled salbutamol. Curr Med Res Opin. 1986;10(4):228–234. doi: 10.1185/03007998609110443. [DOI] [PubMed] [Google Scholar]
  4. Butchers P. R., Skidmore I. F., Vardey C. J., Wheeldon A. Characterization of the receptor mediating the antianaphylactic effects of beta-adrenoceptor agonists in human lung tissue in vitro. Br J Pharmacol. 1980;71(2):663–667. doi: 10.1111/j.1476-5381.1980.tb10987.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cockcroft D. W., Murdock K. Y. Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine. J Allergy Clin Immunol. 1987 May;79(5):734–740. doi: 10.1016/0091-6749(87)90204-1. [DOI] [PubMed] [Google Scholar]
  6. Crane J., Burgess C., Beasley R. Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline. Thorax. 1989 Feb;44(2):136–140. doi: 10.1136/thx.44.2.136. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Feldman R. D., Hunninghake G. W., McArdle W. L. Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes. J Immunol. 1987 Nov 15;139(10):3355–3359. [PubMed] [Google Scholar]
  8. Grainger J., Woodman K., Pearce N., Crane J., Burgess C., Keane A., Beasley R. Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control study. Thorax. 1991 Feb;46(2):105–111. doi: 10.1136/thx.46.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Haahtela T., Järvinen M., Kava T., Kiviranta K., Koskinen S., Lehtonen K., Nikander K., Persson T., Reinikainen K., Selroos O. Comparison of a beta 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med. 1991 Aug 8;325(6):388–392. doi: 10.1056/NEJM199108083250603. [DOI] [PubMed] [Google Scholar]
  10. Harvey J. E., Tattersfield A. E. Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects. Thorax. 1982 Apr;37(4):280–287. doi: 10.1136/thx.37.4.280. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hauck R. W., Böhm M., Gengenbach S., Sunder-Plassmann L., Fruhmann G., Erdmann E. Beta 2-adrenoceptors in human lung and peripheral mononuclear leukocytes of untreated and terbutaline-treated patients. Chest. 1990 Aug;98(2):376–381. doi: 10.1378/chest.98.2.376. [DOI] [PubMed] [Google Scholar]
  12. Inman W. H., Adelstein A. M. Rise and fall of asthma mortality in England and Wales in relation to use of pressurised aerosols. Lancet. 1969 Aug 9;2(7615):279–285. doi: 10.1016/s0140-6736(69)90051-8. [DOI] [PubMed] [Google Scholar]
  13. Jenkins M. M., Hilton C. J., de Kock J. C., Palmer J. B. Exacerbations of asthma in patients on salmeterol. Lancet. 1991 Apr 13;337(8746):913–914. doi: 10.1016/0140-6736(91)90242-h. [DOI] [PubMed] [Google Scholar]
  14. Kerrebijn K. F., van Essen-Zandvliet E. E., Neijens H. J. Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma. J Allergy Clin Immunol. 1987 Apr;79(4):653–659. doi: 10.1016/s0091-6749(87)80163-x. [DOI] [PubMed] [Google Scholar]
  15. Kraan J., Koëter G. H., vd Mark T. W., Sluiter H. J., de Vries K. Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline. J Allergy Clin Immunol. 1985 Oct;76(4):628–636. doi: 10.1016/0091-6749(85)90786-9. [DOI] [PubMed] [Google Scholar]
  16. Löfdahl C. G., Chung K. F. Long-acting beta 2-adrenoceptor agonists: a new perspective in the treatment of asthma. Eur Respir J. 1991 Feb;4(2):218–226. [PubMed] [Google Scholar]
  17. Molfino N. A., Nannini L. J., Martelli A. N., Slutsky A. S. Respiratory arrest in near-fatal asthma. N Engl J Med. 1991 Jan 31;324(5):285–288. doi: 10.1056/NEJM199101313240502. [DOI] [PubMed] [Google Scholar]
  18. Page C. P. One explanation of the asthma paradox: inhibition of natural anti-inflammatory mechanism by beta 2-agonists. Lancet. 1991 Mar 23;337(8743):717–720. doi: 10.1016/0140-6736(91)90289-2. [DOI] [PubMed] [Google Scholar]
  19. Patakas D., Maniki E., Tsara V., Daskalopoulou E. Intermittent and continuous salbutamol rotacaps inhalation in asthmatic patients. Respiration. 1988;54(3):174–178. doi: 10.1159/000195518. [DOI] [PubMed] [Google Scholar]
  20. Pearce N., Grainger J., Atkinson M., Crane J., Burgess C., Culling C., Windom H., Beasley R. Case-control study of prescribed fenoterol and death from asthma in New Zealand, 1977-81. Thorax. 1990 Mar;45(3):170–175. doi: 10.1136/thx.45.3.170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Persson C. G., Ekman M., Erjefält I. Vascular anti-permeability effects of beta-receptor agonists and theophylline in the lung. Acta Pharmacol Toxicol (Copenh) 1979 Mar;44(3):216–220. doi: 10.1111/j.1600-0773.1979.tb02320.x. [DOI] [PubMed] [Google Scholar]
  22. Salome C. M., Schoeffel R. E., Woolcock A. J. Effect of aerosol and oral fenoterol on histamine and methacholine challenge in asthmatic subjects. Thorax. 1981 Aug;36(8):580–584. doi: 10.1136/thx.36.8.580. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Scheinin M., Koulu M., Laurikainen E., Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol. 1987 Nov;24(5):645–653. doi: 10.1111/j.1365-2125.1987.tb03224.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Sears M. R. Dose reduction of beta-agonists in asthma. Lancet. 1991 Nov 23;338(8778):1331–1332. doi: 10.1016/0140-6736(91)92627-e. [DOI] [PubMed] [Google Scholar]
  25. Sears M. R., Rea H. H. Patients at risk for dying of asthma: New Zealand experience. J Allergy Clin Immunol. 1987 Sep;80(3 Pt 2):477–481. doi: 10.1016/0091-6749(87)90079-0. [DOI] [PubMed] [Google Scholar]
  26. Shepherd G. L., Hetzel M. R., Clark T. J. Regular versus symptomatic aerosol bronchodilator treatment of asthma. Br J Dis Chest. 1981 Apr;75(2):215–217. doi: 10.1016/0007-0971(81)90057-7. [DOI] [PubMed] [Google Scholar]
  27. Shepherd G. L., Jenkins W. J., Alexander J. Asthma exacerbations in patients taking regular salmeterol, or salbutamol for symptoms. Lancet. 1991 Jun 8;337(8754):1424–1424. doi: 10.1016/0140-6736(91)93118-s. [DOI] [PubMed] [Google Scholar]
  28. Speizer F. E., Doll R., Heaf P. Observations on recent increase in mortality from asthma. Br Med J. 1968 Feb 10;1(5588):335–339. doi: 10.1136/bmj.1.5588.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Spitzer W. O., Suissa S., Ernst P., Horwitz R. I., Habbick B., Cockcroft D., Boivin J. F., McNutt M., Buist A. S., Rebuck A. S. The use of beta-agonists and the risk of death and near death from asthma. N Engl J Med. 1992 Feb 20;326(8):501–506. doi: 10.1056/NEJM199202203260801. [DOI] [PubMed] [Google Scholar]
  30. Subramanian N. Inhibition of immunological and non-immunological histamine release from human basophils and lung mast cells by formoterol. Arzneimittelforschung. 1986 Mar;36(3):502–505. [PubMed] [Google Scholar]
  31. Tandon M. K. Cardiopulmonary effects of fenoterol and salbutamol aerosols. Chest. 1980 Mar;77(3):429–431. doi: 10.1378/chest.77.3.429. [DOI] [PubMed] [Google Scholar]
  32. Tokuyama K., Lötvall J. O., Löfdahl C. G., Barnes P. J., Chung K. F. Inhaled formoterol inhibits histamine-induced airflow obstruction and airway microvascular leakage. Eur J Pharmacol. 1991 Jan 25;193(1):35–39. doi: 10.1016/0014-2999(91)90197-x. [DOI] [PubMed] [Google Scholar]
  33. Twentyman O. P., Finnerty J. P., Harris A., Palmer J., Holgate S. T. Protection against allergen-induced asthma by salmeterol. Lancet. 1990 Dec 1;336(8727):1338–1342. doi: 10.1016/0140-6736(90)92894-n. [DOI] [PubMed] [Google Scholar]
  34. Twentyman O. P., Finnerty J. P., Holgate S. T. The inhibitory effect of nebulized albuterol on the early and late asthmatic reactions and increase in airway responsiveness provoked by inhaled allergen in asthma. Am Rev Respir Dis. 1991 Oct;144(4):782–787. doi: 10.1164/ajrccm/144.4.782. [DOI] [PubMed] [Google Scholar]
  35. Ullman A., Hedner J., Svedmyr N. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Am Rev Respir Dis. 1990 Sep;142(3):571–575. doi: 10.1164/ajrccm/142.3.571. [DOI] [PubMed] [Google Scholar]
  36. Vandewalker M. L., Kray K. T., Weber R. W., Nelson H. S. Addition of terbutaline to optimal theophylline therapy. Double blind crossover study in asthmatic patients. Chest. 1986 Aug;90(2):198–203. doi: 10.1378/chest.90.2.198. [DOI] [PubMed] [Google Scholar]
  37. Vathenen A. S., Knox A. J., Higgins B. G., Britton J. R., Tattersfield A. E. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancet. 1988 Mar 12;1(8585):554–558. doi: 10.1016/s0140-6736(88)91352-9. [DOI] [PubMed] [Google Scholar]
  38. Wallin A., Melander B., Rosenhall L., Sandström T., Wåhlander L. Formoterol, a new long acting beta 2 agonist for inhalation twice daily, compared with salbutamol in the treatment of asthma. Thorax. 1990 Apr;45(4):259–261. doi: 10.1136/thx.45.4.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Weber R. W., Smith J. A., Nelson H. S. Aerosolized terbutaline in asthmatics: development of subsensitivity with long-term administration. J Allergy Clin Immunol. 1982 Dec;70(6):417–422. doi: 10.1016/0091-6749(82)90003-3. [DOI] [PubMed] [Google Scholar]
  40. White P. C., New M. I., Dupont B. Cloning and expression of cDNA encoding a bovine adrenal cytochrome P-450 specific for steroid 21-hydroxylation. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1986–1990. doi: 10.1073/pnas.81.7.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Wong C. S., Pavord I. D., Williams J., Britton J. R., Tattersfield A. E. Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma. Lancet. 1990 Dec 8;336(8728):1396–1399. doi: 10.1016/0140-6736(90)93099-b. [DOI] [PubMed] [Google Scholar]
  42. van Schayck C. P., Dompeling E., van Herwaarden C. L., Folgering H., Verbeek A. L., van der Hoogen H. J., van Weel C. Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study. BMJ. 1991 Dec 7;303(6815):1426–1431. doi: 10.1136/bmj.303.6815.1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. van Schayck C. P., Graafsma S. J., Visch M. B., Dompeling E., van Weel C., van Herwaarden C. L. Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol. J Allergy Clin Immunol. 1990 Nov;86(5):793–800. doi: 10.1016/s0091-6749(05)80185-x. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES